Ophthalmology is the highest volume outpatient specialty within the NHS and the medicines used for medical retinal vascular conditions account for some of the highest cost and volume treatments used ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

This retrospective, single-centre observational study evaluated the efficacy of intravitreal dexamethasone implant in the management of stromal choroiditis in Birdshot retinochoroiditis refractory to ...

Objective: To investigate the relationship between the implantation position of dexamethasone intravitreal implant (DEX-I) and post-injection intraocular pressure (IOP) elevation. Methods: This ...

Dexamethasone has possible interactions with some other drugs and certain supplements. Examples include ibuprofen (Advil, Motrin) and metformin (Fortamet, Glumetza). Talk with your doctor to avoid ...

Investigators evaluated the clinical benefit of a sustained‐release dexamethasone intravitreal implant as a second‐line treatment for DME. The Ozurdex implant is noninferior to switching intravitreal ...

We report two cases of stage 3A unilateral Coats’ disease in pediatric patients. In both cases, disease control was achieved using a dexamethasone intravitreal implant in addition to other treatments.

The prescribed dosage for dexamethasone may vary depending on a person’s individual treatment plan. Factors such as your medical history and body weight may also affect your dosage of dexamethasone.

One intravitreal injection of the dexamethasone implant in patients with refractory DME induced significant anatomic and functional improvements, but these improvements only lasted for short periods ...

The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects of one intravitreal dexamethasone implant in eyes with refractory diabetic ...

The prescribed dosage for dexamethasone may depend on a person’s treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your dosage of ...

Significantly fewer patients in the fluocinolone acetonide intravitreal implant group experienced recurrence of uveitis at 6 months compared with the sham group. The Food and Drug Administration (FDA) ...